Clarity Pharmaceuticals (ASX: CU6) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Clarity Pharmaceuticals Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Clarity Pharmaceuticals (ASX: CU6)
Latest News
Share Fallers
Why Clarity Pharmaceuticals, GQG Partners, Light & Wonder, and QBE shares are dropping today
Share Gainers
Here are the top 10 ASX 200 shares today
Share Gainers
Here are the top 10 ASX 200 shares today
Share Gainers
Why Bellevue Gold, Bubs, Clarity Pharmaceuticals, and Regal Partners shares are rising today
Healthcare Shares
Broker says this ASX 200 biotech stock is a top buy
Share Gainers
Here are the top 10 ASX 200 shares today
Share Gainers
Why Auckland Airport, Australian Ethical, Breville, and Clarity shares are charging higher
Healthcare Shares
Guess which ASX 200 stock just jumped 9% on big news
Share Gainers
Here are the top 10 ASX 200 shares today
Share Gainers
Here are the top 10 ASX 200 shares today
Share Gainers
Here are the top 10 ASX 200 shares today
Healthcare Shares
Two ASX healthcare shares that could be set to double
CU6 ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Clarity Pharmaceuticals
Clarity Pharmaceuticals Ltd. is a clinical stage radiopharmaceutical company. It engages in research and development and clinical stage evaluation of its portfolio of novel radiopharmaceuticals products. The company was founded by Matthew Harris on April 8, 2010 and is headquartered in Eveleigh, Australia.